Veterinary Molecular Diagnostics Market Size & Share 2025 – 2034

Veterinary Molecular Diagnostics Market Size

The global veterinary molecular diagnostics market was valued at USD 647.8 million in 2024. The market is anticipated to grow from USD 692.4 million in 2025 to USD 1.4 billion in 2034, growing at a CAGR of 7.9% from 2025 to 2034. The market is growing as a result of increasing prevalence of several infectious diseases in animals which necessitate advanced diagnostic tools. Moreover, rising awareness of early diagnosis among pet owners along with increase in adoption of pets, has further boosted demand for veterinary molecular diagnostic solutions.

High growth in the market can be attributed to the rising population of both companion and livestock animals. As per the World Animal Foundation estimates, the companion animal population reached approximately 967 million worldwide, of which 522 million were dogs and 445 million were cats.  Similarly, according to FAO, the global ruminant livestock population is roughly 3.6 billion, of which approximately 2 billion represents the total number of livestock animals used for meat and dairy products. Further, the global poultry population has reached an astounding 26 billion. Such a high volume of animals increases the demand for various animal healthcare products and veterinary services, including diagnostic solutions such as molecular diagnostics, thereby boosting the market growth.
 

Furthermore, availability of advanced medical facilities for pets, cutting-edge diagnostic laboratories, increasing number of veterinary hospitals and clinics, and high adoption of pet insurance are further set to positively impact industry growth. Further, several technological advancements in the field of veterinary medicine are set to positively influence the veterinary molecular diagnostics industry. Further, the increasing occurrence of zoonotic diseases as well as the possibility of infectious outbreaks in companion and livestock animals have been propelling the veterinary molecular diagnostics market.
 

There are stricter policies pertaining to the health of animals due to concerns regarding food security globally. These policies have led to the implementation of various animal health and wellness programs aimed at ensuring disease control. Regulatory authorities across the world are imposing strict policies to prevent the outbreak of animal-borne diseases by implementing stricter diagnosis and treatment policies, thus contributing to the overall market growth.
 

Veterinary molecular diagnostics refers to the use of molecular techniques such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarray, to diagnose infectious diseases, genetic disorders, and other conditions in animals. The market includes the products used for the analysis of animal DNA, RNA, and proteins to identify specific nucleic acid sequences or mutations associated with disease or predisposition to disease.
 

Veterinary Molecular Diagnostics Market Trends

• Growing trend of pet adoption and humanization has positively influenced the adoption of veterinary molecular diagnostics. High disposable income has further augmented the spending on animal healthcare.
   
• Majority of pet owners consider their pet as a family member; hence they undertake numerous efforts to take proper care of their pets.
   
• According to recent data, published in 2019, nearly 68% of households in the U.S. at present own a pet. This has created a substantial demand for the pet care services and products that are set to proliferate the demand for diagnostic solutions, thereby boosting the market growth.
   
• Further, a rise in the global demand for livestock products owing to an increase in population, rising incomes, and urbanization has boosted the population of livestock animals. Also, the growing focus on food safety and the increasing adoption of animal-derived products expand the market potential of veterinary molecular diagnostics.
   
• Rising incidence of infectious and zoonotic diseases in animals also aids in the market growth.  According to an article published by the World Health Organization (WHO) in 2021, zoonotic diseases account for over 60% of emerging infectious diseases globally. The COVID-19 pandemic, believed to have originated as a zoonotic transmission, underscored the risks associated with animal-to-human disease spread. Outbreaks of avian influenza, rabies, and coronaviruses have further emphasized the need for early detection, monitoring, and prevention.
   
• Foodborne zoonotic diseases, caused by Salmonella, Campylobacter, E. coli, Yersinia, and Listeria, remain a major concern, particularly in regions with high consumption of animal-derived food products. Contaminated animal feed and farm environments contribute to human infections, leading to widespread health risks.
   
• Furthermore, according to the European Food Safety Authority, over 350,000 human cases of foodborne zoonotic diseases are reported annually in Europe, highlighting the urgency of improved food safety measures.
   
• Globally, molecular diagnostic techniques, including PCR and DNA sequencing, play a crucial role in detecting and monitoring zoonotic pathogens in companion animals, livestock, and wildlife. The rising awareness of zoonotic diseases and their impact on public health has driven investments in advanced veterinary diagnostics, fostering innovation in disease surveillance, prevention, and control.
   
• Moreover, high adoption of pet insurance is expected to be an instrumental factor in driving the market expansion. According to the North American Pet Health Insurance Association, there has been an increase of about 18% in the number of insured pets during 2017-2018, in the U.S. Further, the number of insured pets in 2021 was 26% higher than in 2020 and 63% higher than in 2018. Thus, surging demand for pet insurance coupled with the growing number of insured animals will drive the market expansion.
   
• Technological advancements have significantly enhanced the accuracy, efficiency, and scope of veterinary molecular and immunodiagnostic testing, enabling early disease detection and improved treatment outcomes.
   
• Leading players such as Zoetis, IDEXX Laboratories, and MiDOG Animal Diagnostics are focusing on point-of-care (POC) molecular diagnostic solutions, allowing pet owners and veterinarians to access real-time results for infectious disease screening, blood chemistry analysis, and hormone testing. In June 2022, IDEXX Laboratories expanded its reference laboratory menu by introducing Next-Day PCR Direct Testing Service, improving diagnostic turnaround times. Such initiatives by key market players will further strengthen the market growth.
   

Veterinary Molecular Diagnostics Market Analysis

Based on the product, the market is segmented into kits and reagents and instruments. The kits and reagents segment accounted for the highest market share and was valued at USD 450.7 million in 2024.
 

• Unlike instruments, kits, and reagents are used in every molecular test, leading to continuous replenishment needs. Hence, as the veterinary testing volume rises, so does the demand for these consumables. This ensures steady revenue and growth in the kits and reagents used in the veterinary filed.
   
• Furthermore, the rising frequency of animal disease outbreaks has increased the demand for diagnostic testing. For example, as per the World Organization for Animal Health (WOAH), over 3,500 highly pathogenic avian influenza outbreaks were reported across 67 countries in 2022, a 35% increase from 2021. Further, the U.S. Department of Agriculture (USDA) reported that bovine viral diarrhea (BVD) testing volumes increased by 28% between 2021 and 2023 in commercial cattle operations. Such increasing prevalence of infectious diseases necessitates testing, thus increasing the demand for kits and reagents.
   
• Furthermore, as per the European Union Reference Laboratory data, the use of molecular diagnostic kits in veterinary settings grew by 42% from 2021 to 2023, particularly within commercial livestock health monitoring programs. This growth has helped secure a leading position for the kits and reagents segment within the broader veterinary diagnostics landscape.
   

Based on the technology, the veterinary molecular diagnostics market is classified into PCR, DNA sequencing, microarrays, and INAAT kits. The PCR segment accounted for the highest market revenue in 2024 with a market share of 66.2%. The segment is further divided into real time PCR and other PCR.
 

• PCR-based tests hold a significant share owing to their sensitivity, specificity, and speed. The polymerase chain reaction (PCR) test process permits amplification of nucleic acid extracts from biological samples, thus enabling earlier and precise diagnosis of infectious diseases.
   
• Additionally, pathogen detection during the latent or subclinical phases of diseases enhances surveillance and prevention strategies in both livestock and companion animals. Such accuracy and dependability make PCR a major breakthrough in molecular diagnostics and veterinary medicine, thus increasing the adoption of these tests.
   
• Furthermore, innovations like real-time (qPCR) and multiplex PCR enable multifunctional testing within a single framework, thus optimizing workflow and improving clinical evaluations.
   
• Such advancements continue to widen the applications of PCR in veterinary routine diagnostics and epidemiological studies, further strengthening its market share in the market.
   

Based on the application, the veterinary molecular diagnostics market is classified into infectious diseases, genetic diseases, and other applications. The infectious diseases segment accounted for the highest market revenue of USD 328.6 million in 2024 and is poised to grow at a CAGR of 8.3%. The segment is further categorized into bacterial infectious diseases, viral infectious diseases, parasitic infectious diseases, and other infectious diseases.
 

• Infectious diseases, including bovine viral diarrhea (BVD), foot-and-mouth disease, canine parvovirus, and feline leukemia, affect multiple animal species. For instance, according to the World Organization for Animal Health (WOAH), in 2023, over 8,500 outbreaks of foot-and-mouth disease were reported across 23 countries.
   
• In addition, the American Veterinary Medical Association documented a 12% increase in canine parvovirus cases between 2021 and 2023. These diseases significantly impact animal health, productivity, and survival rates.
   
• Molecular diagnostic methods enable early detection, which is essential for effective outbreak management. The continuous risk of these diseases increases the demand for precise diagnostic tools.
   
• Moreover, livestock and companion animals are susceptible to various infectious diseases, including parvovirus, bovine viral diarrhea (BVD), avian influenza, and leptospirosis. These conditions can lead to serious health complications and considerable economic losses.
   
• The high prevalence of such diseases necessitates rapid and accurate diagnostic solutions. Molecular methods, such as polymerase chain reaction (PCR), are favored for their sensitivity and early detection capabilities, thereby driving segmental growth.
   

Based on the animal type, the veterinary molecular diagnostics market is classified into companion animals and livestock animals. The companion animals segment accounted for the highest market revenue of USD 416.3 million in 2024 and is anticipated to reach USD 901.1 million by 2034.
 

• This substantial growth is attributed to the rising adoption rate of animals such as dogs, cats, birds, and horses as pets.
   
• More than half of the global population is estimated to have a pet at home. Globally, dogs are the most popular pet, present in around one in three homes. Almost a quarter of pet owners have a cat. Thus, the sheer number of companion animals along with increased spending is expected to propel the segmental growth.
   
• Furthermore, the American Veterinary Medical Association reported a 12% increase in veterinary visits between 2021 and 2023, with diagnostic testing accounting for 25% of all veterinary procedures. This growth has expanded the market for molecular diagnostic tests tailored to companion animals.
   
• Further, growing disposable income in developing economies and launch of advanced animal healthcare products will spur segment growth during the forecast timeframe.
   

Based on the end use, the veterinary molecular diagnostics market is categorized into diagnostic laboratories, veterinary clinics, veterinary hospitals, and other end users. The diagnostic laboratories segment is expected to grow at a CAGR of 7.6% between 2025 - 2034.
 

• Diagnostic laboratories hold a dominant share in the market because of their sophisticated infrastructure, trained personnel, and capability to efficiently manage large sample volumes with high accuracy.
   
• These laboratories have advanced molecular diagnostic systems like PCR machines, real-time PCR, and next-generation sequencing tools, which enable timely and precise identification of microorganisms, genetic alterations, and other associated markers in tissues and fluids from animals.
•  
• Such capabilities make them a preferred partner for veterinarians and animal healthcare practitioners.
   
• Furthermore, these laboratories often act as central referral testing laboratories for veterinarians who cannot perform molecular diagnostics in-house.
   
• Moreover, the shift towards precision veterinary medicine, coupled with the increasing need for early diagnostics, has also emphasized the role of diagnostic labs.
   

North America dominates the global veterinary molecular diagnostics market with a market size of USD 319 million in 2024 and is anticipated to reach USD 685.7 million by 2034, growing at a CAGR of 8.1% between 2025 - 2034.
 

The U.S. market was valued at USD 244.3 million and USD 257.5 million in 2021 and 2022, respectively. The market size reached USD 291.3 million in 2024, growing from USD 273.2 million in 2023.
 

• High rates of pet ownership in the country, coupled with the availability of advanced pet care services, drive market growth.
   
• For instance, as of 2023, over 66% of Americans, which translates to about 87 million homes, owned at least one pet. Also, the region has a strong livestock industry, which further increases the demand for veterinary diagnostics.
   
• Additionally, rising expenditure on animal care and strong veterinary infrastructure increases the adoption of veterinary molecular diagnostics.
   
• Also, the high adoption of pet insurance in the region contributes to the overall market growth.
   

Europe veterinary molecular diagnostics market accounted for USD 150.8 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Rising pet adoption in the region, coupled with increasing initiatives by the government to improve animal healthcare, is anticipated to spur market growth.
   
• Moreover, advancements in veterinary services with the frequent introduction of superior veterinary diagnostic products and services for accurate diagnosis will boost the market in the European region.
   
• Also, the presence of key market players in the region reinforces Europe’s strength in the market. These companies are actively participating in innovation through the development of innovative solutions, thereby aiding market growth.
   

Germany veterinary molecular diagnostics market is anticipated to witness considerable growth over the analysis period.
 

• The country’s well-established veterinary practices and research institutions, along with its emphasis on high-quality veterinary services, contribute to the widespread adoption of veterinary molecular diagnostics technology.
   
• The rising adoption of pet and livestock animals, coupled with surging expenditure on veterinary care, is also set to augment the market in Germany.
   
• For example, as of 2023, 45% of German households have a pet and 14% of households have two pets or more. This totals approximately 34.3 million pets. Cats and dogs are the most popular house pets, with 25% of German households owning cats and 21% of households owning dogs. Moreover, in 2024, the cattle population in Germany was 10.63 million. Such a high volume of pets and livestock animals increases the demand for effective diagnostic solutions, thus boosting market growth.
   
• Additionally, Germany’s role as a hub for innovation in veterinary diagnostics further solidifies its position as a leader in the market, catering to both domestic and international demand for reliable and efficient veterinary solutions.
   

The Asia Pacific veterinary molecular diagnostics market is anticipated to witness significant growth over the analysis timeframe.
 

• The market in the Asia Pacific region is growing rapidly due to the rise in pet ownership, advancements in animal health awareness, and the improvement of veterinary care infrastructure.
   
• Countries such as China, India and Japan are adopting diagnostic technology at a faster rate owing to the enhanced demand for better veterinary services and an increase in livestock management activities.
   
• Additionally, the rapid rise in the number of veterinary clinics, hospitals, and diagnostic laboratories, coupled with government policies aimed at animal health care, contribute to the rapid growth of the market in the region.
   

India veterinary molecular diagnostics market is predicted to grow significantly over the forecast period.

• India has a large pet population with over 31 million pet dogs and 2.44 million pet cats. The increasing pet ownership and rising disposable income in the country, coupled with high expenditure on pet healthcare, will offer lucrative market growth opportunities in the country.
   
• In addition, rapidly expanding veterinary infrastructure in the country such as veterinary hospitals and clinics, will further enhance the market growth.
   
• Furthermore, several government initiatives to support animal health and wellness also stimulate the market growth. For instance, the National Animal Disease Control Programme is a flagship scheme launched in 2019 that aims to control the spread of various animal diseases by increasing testing and disease monitoring. Such initiatives will further drive the market growth.
   

Brazil is experiencing significant growth in the Latin America veterinary molecular diagnostics market due to the increasing demand for advanced diagnostic tools in veterinary care.
 

• Brazil holds a leading position in the Latin American market, driven by its substantial livestock industry, increasing pet ownership, and advancements in veterinary diagnostics.
   
• Brazil has the third-largest pet population in the world, with 160 million pets, of which 60 million are dogs, 30 million cats, and 32 million pet-owning households.
   
• The country is also home to a large livestock population, with Brazil being the third-largest cattle producer and second-largest beef exporter in the world.
   
• Such high animal volume, coupled with strong growth in veterinary expenditure, is anticipated to foster market growth.
   
• Additionally, the country's significant demand for animal-derived food products, government initiatives to enhance agricultural and animal health outcomes, and a rising incidence of zoonotic diseases further boost the market growth.
   

South Africa veterinary molecular diagnostics market is poised to witness substantial growth in Middle East and Africa market during the forecast period.
 

• About 45% of adults in South Africa are pet owners, showcasing the country’s love for animals. Among these, 78% are dog owners, while only 36% own cats.
   
• The increasing pet ownership in the country, rising disposable income, coupled with a rapidly expanding veterinary infrastructure, will offer lucrative market growth opportunities in the country.
   
• In addition, rising government initiatives to boost animal welfare and support businesses in the veterinary industry aid in the market growth.
   

Veterinary Molecular Diagnostics Market Share

The global market is fragmented, with key pharmaceutical and biotech companies leading the space, while early-stage innovation remains active among smaller firms. Major market players are employing strategic initiatives such as partnerships, acquisitions, product innovation, and geographic expansion to strengthen their market positions and stay ahead of the competition. The top 4 players, such as IDEXX Laboratories, Zoetis, Qiagen, and Neogen Corporation, account for approximately 48% - 50% of the global market. These industry leaders focus on advancing novel testing methodologies and optimizing existing diagnostic platforms to enhance animal health outcomes.
 

Additionally, there are several local and regional players operating in the market who are boosting competition by providing affordable options at lower costs. These players are also involved in several strategies such as mergers, acquisitions, and novel product launches to expand their product offerings.
 

Veterinary Molecular Diagnostics Market Companies

Few of the prominent players operating in the veterinary molecular diagnostics industry include:

• Agrolabo
• bioMerieux
• BIONOTE
• Bioneer Corporation
• Bio-Rad Laboratories
• GZ MED
• Heska Corporation
• Idexx Laboratories
• INDICAL BIOSCIENCE
• Innovative Diagnostics
• Neogen Corporation
• QIAGEN
• Thermo Fisher Scientific
• Veterinary Molecular Diagnostics
• Zoetis
   

IDEXX Laboratories is a key player in veterinary molecular diagnostics, commanding a high market share through its extensive portfolio of in-clinic analyzers, PCR tests, and rapid assays. The company continues to innovate with products like the IDEXX BioAnalytics System and the Cystatin B test, enhancing early disease detection in companion animals. Despite recent challenges such as reduced veterinary visits and currency fluctuations, IDEXX maintains a strong market position, supported by its robust research and development investments and comprehensive diagnostic solutions.
 

Zoetis is a prominent player in the market, offering advanced diagnostic solutions that support early and accurate detection of infectious diseases in animals. The company’s molecular diagnostic portfolio includes PCR-based testing platforms and genetic testing services, primarily for companion animals and livestock. Zoetis enhances veterinary care by integrating diagnostics with therapeutics, enabling targeted and efficient treatment strategies.
 

Veterinary Molecular Diagnostics Industry News

• In January 2025, IDEXX Laboratories launched IDEXX Cancer Dx, a diagnostic panel designed for early detection of canine lymphoma. The company plans to expand the panel over the next three years to cover the majority of canine cancer cases, reinforcing its leadership in veterinary oncology diagnostics.
   
• In June 2023, Neogen Corporation launched My CatScan 2.0, a significantly upgraded and improved version of the test for genetic screening of cats. This strategy helped the company to enhance the product portfolio and drive revenue growth.
   
• In November 2022, INDICAL BIOSCIENCE announced the launch of its updated virotype 2.0 PCR kit range, featuring a harmonized, validated, and more efficient design. The new kits introduced a streamlined reaction setup and a unified cycling protocol across all assays. It simplified laboratory workflows, reduced training time, and improved operational efficiency in veterinary molecular diagnostics.
   
• In July 2022, Bionote USA Inc partnered with PSIvet. This strategic partnership was aimed to enables Bionote USA’s Vcheck line of analyzers and tests even more affordable to PSIvet’s 5,000 and over veterinary practices. This strategy helped the company to strengthen business relations, outreach to untapped economies and increase customer base.
   
• In June 2022, IDEXX Laboratories, Inc expanded the reference laboratory menu by including Fecal Dx Antigen Testing with Flea Tapeworm Detection, Testing for the FGF-23 Kidney Biomarker, and Next-Day PCR Direct Testing Service.  This strategy helped the company to enhance its existing product portfolio and increase customer base.
   

The veterinary molecular diagnostics market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Kits and reagents
• Instruments

Market, By Technology

• PCR
  • Real time PCR
  • Other PCR
• DNA sequencing
• Microarray
• INAAT kits    

Market, By Application

• Infectious diseases
  • Bacterial infectious diseases
  • Viral infectious diseases
  • Parasitic infectious diseases
  • Other infectious diseases
• Genetic diseases
• Other applications

Market, By Animal Type

• Companion animals
  • Dogs
  • Cats
  • Horses
  • Other companion animals
• Livestock animals
  • Cattle
  • Swine
  • Poultry
  • Other livestock animals

Market, By End Use

• Diagnostic laboratories
• Veterinary clinics
• Veterinary hospitals
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE